West Pharmaceutical Services (WST) EBITDA (2009 - 2026)
West Pharmaceutical Services (WST) EBITDA from Jun 30, 2009 to Mar 31, 2026. The TTM West Pharmaceutical Services (WST) EBITDA is $832M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual EBITDA
Quarterly EBITDA
West Pharmaceutical Services (WST) EBITDA CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +16.49% |
| 3 Years TTM | +0.38% |
| 5 Years TTM | +6.51% |
| 10 Years TTM | +15.24% |
| All Time TTM | +14.06% |
Annual EBITDA change of West Pharmaceutical Services (WST)
| Year | EBITDA | Change |
|---|---|---|
| 2026 | $222M | -70.61% |
| 2025 | $756M | +4.27% |
| 2024 | $725M | -10.82% |
| 2023 | $813M | -4.83% |
| 2022 | $855M | -2.29% |
| 2021 | $875M | +69.50% |
| 2020 | $516M | +29.00% |
| 2019 | $400M | +16.04% |
| 2018 | $345M | +6.88% |
| 2017 | $323M | +12.80% |
| 2016 | $286M | +30.85% |
| 2015 | $219M | -19.67% |
| 2014 | $272M | +9.85% |
| 2013 | $248M | +16.79% |
| 2012 | $212M | +14.41% |
| 2011 | $185M | +13.06% |
| 2010 | $164M | +1.55% |
| 2009 | $161M | -10.43% |
| 2008 | $180M | N/A |
Comparison West Pharmaceutical Services (WST) five years EBITDA CAGR with competitors
West Pharmaceutical Services (WST) five years EBITDA CAGR is 6.51%.
| Ticker | Name | five years EBITDA CAGR | Upside |
|---|---|---|---|
| POCI | Precision Optics Corp Inc | 111.37% | +1610.86% |
| NYXH | Nyxoah SA | 45.05% | +592.06% |
| GCTK | GlucoTrack Inc | 38.94% | +498.13% |
| STXS | Stereotaxis Inc | 28.84% | +343.02% |
| ZTEK | Zentek Ltd | 26.96% | +314.15% |
| RGNT | Regentis Biomaterials Ltd | 26.85% | +312.42% |
| MMSI | Merit Medical Systems Inc | 24.73% | +279.91% |
| BLFS | Biolife Solutions Inc | 22.17% | +240.52% |
| ISRG | Intuitive Surgical Inc | 21.90% | +236.50% |
| RGEN | Repligen Corp | 15.86% | +143.59% |
| RMD | Resmed Inc | 15.14% | +132.66% |
| ALC | Alcon Inc | 14.84% | +128.03% |
| LMAT | Lemaitre Vascular Inc | 14.82% | +127.71% |
| PDEX | Pro-Dex Inc (co) | 13.53% | +107.79% |
| ANGO | Angiodynamic Inc | 12.62% | +93.92% |
| MBOT | Microbot Medical Inc | 11.58% | +77.93% |
| STVN | Stevanato Group Spa | 9.34% | +43.42% |
| COO | Cooper Companies Inc | 7.73% | +18.76% |
| NXGL | Nexgel Inc | 7.05% | +8.26% |
| ATR | Aptargroup Inc | 6.79% | +4.35% |
| PLSE | Pulse Biosciences Inc | 6.69% | +2.81% |
| ICUI | ICU Medical Inc | 5.71% | -12.32% |
| ALGN | Align Technology Inc | 4.82% | -25.89% |
| EKSO | Ekso Bionics Holdings Inc | 4.60% | -29.39% |
| BDX | Becton Dickinson & Company | 4.54% | -30.27% |
| NVST | Envista Holdings Corp | 4.52% | -30.54% |